| Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial N Bhandari, T Rongsen-Chandola, A Bavdekar, J John, K Antony, ... The Lancet 383 (9935), 2136-2143, 2014 | 315 | 2014 |
| Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life N Bhandari, T Rongsen-Chandola, A Bavdekar, J John, K Antony, ... Vaccine 32, A110-A116, 2014 | 164* | 2014 |
| Microorganisms associated with pneumonia in children< 5 years of age in developing and emerging countries: the GABRIEL pneumonia multicenter, prospective, case-control study T Bénet, V Sánchez Picot, M Messaoudi, M Chou, T Eap, J Wang, K Shen, ... Clinical Infectious Diseases 65 (4), 604-612, 2017 | 160 | 2017 |
| Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised … ZA Bhutta, MR Capeding, A Bavdekar, E Marchetti, S Ariff, SB Soofi, ... The Lancet infectious diseases 14 (2), 119-129, 2014 | 129 | 2014 |
| A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants PS Kulkarni, S Desai, T Tewari, A Kawade, N Goyal, BS Garg, D Kumar, ... Vaccine 35 (45), 6228-6237, 2017 | 111 | 2017 |
| Severity of pneumonia in under 5-year-old children from developing countries: a multicenter, prospective, observational study T Benet, VS Picot, S Awasthi, N Pandey, A Bavdekar, A Kawade, ... The American journal of tropical medicine and hygiene 97 (1), 68, 2017 | 65 | 2017 |
| Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India J John, A Kawade, T Rongsen-Chandola, A Bavdekar, N Bhandari, ... Vaccine 32, A104-A109, 2014 | 30 | 2014 |
| Interplaying role of healthcare activist and homemaker: a mixed-methods exploration of the workload of community health workers (Accredited Social Health Activists) in India A Kawade, M Gore, P Lele, U Chavan, H Pinnock, P Smith, S Juvekar, ... Human Resources for Health 19, 1-12, 2021 | 23 | 2021 |
| SII BRV-PV author group. A randomized phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants PS Kulkarni, S Desai, T Tewari, A Kawade, N Goyal, BS Garg, D Kumar, ... Vaccine 35 (45), 6228-6237, 2017 | 22 | 2017 |
| Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial A Bavdekar, J Oswal, PV Ramanan, C Aundhkar, P Venugopal, D Kapse, ... Vaccine 36 (9), 1220-1226, 2018 | 21 | 2018 |
| Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in India A Bavdekar, N Malshe, L Ravichandran, A Sapru, A Kawade, S Lalwani, ... Contemporary clinical trials communications 14, 100321, 2019 | 19 | 2019 |
| Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL-Liquid) in Indian infants A Kawade, S Babji, V Kamath, A Raut, CM Kumar, R Kundu, ... Vaccine 37 (19), 2554-2560, 2019 | 18 | 2019 |
| A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent … N Rathi, S Desai, A Kawade, P Venkatramanan, R Kundu, SK Lalwani, ... Vaccine 36 (52), 7943-7949, 2018 | 16 | 2018 |
| Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine S Desai, N Rathi, A Kawade, P Venkatramanan, R Kundu, SK Lalwani, ... Vaccine 36 (37), 5519-5523, 2018 | 16 | 2018 |
| Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study PS Kulkarni, A Kadam, S Godbole, V Bhatt, A Raut, S Kohli, S Tripathi, ... The Lancet Regional Health-Southeast Asia 10, 2023 | 13 | 2023 |
| Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India … H Sharma, S Parekh, P Pujari, S Shewale, S Desai, N Bhatla, S Joshi, ... The Lancet Oncology 24 (12), 1321-1333, 2023 | 9 | 2023 |
| Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open … S Kanungo, P Chatterjee, A Bavdekar, M Murhekar, S Babji, R Garg, ... The Lancet Infectious Diseases 22 (8), 1191-1199, 2022 | 9 | 2022 |
| Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of … NA Serazin, B Edem, SR Williams, JR Ortiz, A Kawade, MK Das, M Šubelj, ... Vaccine 39 (22), 3028-3036, 2021 | 9 | 2021 |
| Nasopharyngeal pneumococcal carriage in South Asian infants: Results of observational cohort studies in vaccinated and unvaccinated populations A Apte, G Dayma, H Naziat, L Williams, S Sanghavi, J Uddin, A Kawade, ... Journal of Global Health 11, 2021 | 9 | 2021 |
| Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0–2-month-old low birth weight infants in India—the “ProSPoNS” Study … AP Sinha, SS Gupta, R Poluru, AV Raut, NK Arora, RM Pandey, AR Sahu, ... Trials 22, 1-12, 2021 | 8 | 2021 |
